Brainomix and Medtronic Partner to Enhance Stroke Care in Western Europe

Brainomix has announced a partnership with Medtronic to integrate AI solutions into stroke care across Western Europe, aiming to improve patient outcomes.

Brainomix has announced a strategic partnership with Medtronic Neurovascular to enhance stroke care across Western Europe by integrating advanced AI solutions into clinical practice, announced in a press release. The collaboration aims to expand access to life-changing treatments and improve patient outcomes.

The Brainomix 360 Stroke platform, powered by AI algorithms, provides real-time interpretation of brain scans to aid treatment decisions for stroke patients. This platform was evaluated in a large-scale study involving over 450,000 patients in England, demonstrating a significant increase in thrombectomy rates at Brainomix sites.

By combining Brainomix's AI imaging technology with Medtronic's neurovascular expertise, the partnership seeks to support faster and more accurate diagnoses. This integration will enable healthcare professionals to make better-informed decisions and deliver life-saving interventions more efficiently across the region.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more